Advances in biomarker-driven and individualized approaches in neurology and psychiatry will require new frameworks for value ...
In this episode of the Capital Compass, we take a closer look at Marvel Biosciences (TSXV:MRVL,OTC:MBCOF), a company ...
As individuals with Alzheimer's disease (AD) move from the mild cognitive impairment stage to moderate and severe dementia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback